MATTHEW HAAG: Open Payments
NPI 1417048737 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 34 payments from 8 companies in 2025. Trend: 2023 $713 · 2024 $642 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $178 |
| PFIZER INC. | 5 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $61 |
| Lilly USA, LLC | 3 | $45 |
| Novo Nordisk Inc | 2 | $37 |
| Exact Sciences Corporation | 2 | $34 |
| Astellas Pharma US Inc | 2 | $32 |
| Abbott Laboratories | 1 | $22 |
Products named: VRAYLAR, NURTEC ODT, CAPLYTA, Veozah, MOUNJARO, QULIPTA, UBRELVY, FREESTYLE LIBRE 3.
Industry payments across OK — which companies pay providers there.
